• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建模 COVID-19 症状的发作。

Modeling the Onset of Symptoms of COVID-19.

机构信息

Quantitative and Computational Biology, Department of Biological Science, University of Southern California, Los Angeles, CA, United States.

USC Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA, United States.

出版信息

Front Public Health. 2020 Aug 13;8:473. doi: 10.3389/fpubh.2020.00473. eCollection 2020.

DOI:10.3389/fpubh.2020.00473
PMID:32903584
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7438535/
Abstract

COVID-19 is a pandemic viral disease with catastrophic global impact. This disease is more contagious than influenza such that cluster outbreaks occur frequently. If patients with symptoms quickly underwent testing and contact tracing, these outbreaks could be contained. Unfortunately, COVID-19 patients have symptoms similar to other common illnesses. Here, we hypothesize the order of symptom occurrence could help patients and medical professionals more quickly distinguish COVID-19 from other respiratory diseases, yet such essential information is largely unavailable. To this end, we apply a Markov Process to a graded partially ordered set based on clinical observations of COVID-19 cases to ascertain the most likely order of discernible symptoms (i.e., fever, cough, nausea/vomiting, and diarrhea) in COVID-19 patients. We then compared the progression of these symptoms in COVID-19 to other respiratory diseases, such as influenza, SARS, and MERS, to observe if the diseases present differently. Our model predicts that influenza initiates with cough, whereas COVID-19 like other coronavirus-related diseases initiates with fever. However, COVID-19 differs from SARS and MERS in the order of gastrointestinal symptoms. Our results support the notion that fever should be used to screen for entry into facilities as regions begin to reopen after the outbreak of Spring 2020. Additionally, our findings suggest that good clinical practice should involve recording the order of symptom occurrence in COVID-19 and other diseases. If such a systemic clinical practice had been standard since ancient diseases, perhaps the transition from local outbreak to pandemic could have been avoided.

摘要

新型冠状病毒肺炎(COVID-19)是一种具有全球灾难性影响的大流行病毒性疾病。这种疾病比流感更具传染性,因此经常发生集群性暴发。如果患者的症状能迅速接受检测和接触者追踪,这些暴发是可以得到控制的。不幸的是,COVID-19 患者的症状与其他常见疾病相似。在这里,我们假设症状出现的顺序可以帮助患者和医务人员更快地将 COVID-19 与其他呼吸道疾病区分开来,但这些重要信息在很大程度上是未知的。为此,我们应用马尔可夫过程对基于 COVID-19 病例临床观察的分级偏序集进行建模,以确定 COVID-19 患者最有可能出现的可识别症状(即发热、咳嗽、恶心/呕吐和腹泻)的顺序。然后,我们比较了 COVID-19 与其他呼吸道疾病(如流感、严重急性呼吸综合征(SARS)和中东呼吸综合征(MERS))的症状进展,以观察疾病是否存在差异。我们的模型预测流感以咳嗽开始,而 COVID-19 则与其他冠状病毒相关疾病一样,以发热开始。然而,COVID-19 在胃肠道症状的出现顺序上与 SARS 和 MERS 不同。我们的研究结果支持这样一种观点,即发热应作为进入医疗机构的筛选标准,因为各地区在 2020 年春季疫情爆发后开始重新开放。此外,我们的研究结果表明,良好的临床实践应包括记录 COVID-19 和其他疾病症状出现的顺序。如果自古代疾病以来就一直采用这种系统的临床实践,那么从局部暴发到大流行的转变也许是可以避免的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc88/7438535/9f101796a7ee/fpubh-08-00473-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc88/7438535/075dc1faf80f/fpubh-08-00473-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc88/7438535/e716ac2f45de/fpubh-08-00473-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc88/7438535/91b85ce9563c/fpubh-08-00473-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc88/7438535/c71803545acd/fpubh-08-00473-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc88/7438535/9f101796a7ee/fpubh-08-00473-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc88/7438535/075dc1faf80f/fpubh-08-00473-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc88/7438535/e716ac2f45de/fpubh-08-00473-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc88/7438535/91b85ce9563c/fpubh-08-00473-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc88/7438535/c71803545acd/fpubh-08-00473-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc88/7438535/9f101796a7ee/fpubh-08-00473-g0006.jpg

相似文献

1
Modeling the Onset of Symptoms of COVID-19.建模 COVID-19 症状的发作。
Front Public Health. 2020 Aug 13;8:473. doi: 10.3389/fpubh.2020.00473. eCollection 2020.
2
Modeling the onset of symptoms of COVID-19: Effects of SARS-CoV-2 variant.建模 COVID-19 症状的发作:SARS-CoV-2 变异的影响。
PLoS Comput Biol. 2021 Dec 16;17(12):e1009629. doi: 10.1371/journal.pcbi.1009629. eCollection 2021 Dec.
3
Travel-related control measures to contain the COVID-19 pandemic: a rapid review.旅行相关的控制措施以遏制 COVID-19 大流行:快速综述。
Cochrane Database Syst Rev. 2020 Oct 5;10:CD013717. doi: 10.1002/14651858.CD013717.
4
Association of Search Query Interest in Gastrointestinal Symptoms With COVID-19 Diagnosis in the United States: Infodemiology Study.美国胃肠道症状搜索查询兴趣与 COVID-19 诊断的关联:信息流行病学研究。
JMIR Public Health Surveill. 2020 Jul 17;6(3):e19354. doi: 10.2196/19354.
5
Seasonal influence on respiratory tract infection severity including COVID-19 quantified through Markov Chain modeling.通过马尔可夫链建模定量季节对呼吸道感染严重程度(包括 COVID-19)的影响。
CPT Pharmacometrics Syst Pharmacol. 2023 Sep;12(9):1250-1261. doi: 10.1002/psp4.13006. Epub 2023 Jul 10.
6
Co-infection of COVID-19 and influenza A in a hemodialysis patient: a case report.COVID-19 与甲型流感病毒在血液透析患者中的合并感染:一例报告。
BMC Infect Dis. 2021 Jan 13;21(1):68. doi: 10.1186/s12879-020-05723-y.
7
Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征的生物学、临床和流行病学特征,以及 ACE2 的 AutoDock 模拟
Infect Dis Poverty. 2020 Jul 20;9(1):99. doi: 10.1186/s40249-020-00691-6.
8
Modeling the Probability of COVID-19 Based on Symptom Screening and Prevalence of Influenza and Influenza-Like Illnesses.基于症状筛查和流感及流感样疾病流行率对 COVID-19 概率建模。
Qual Manag Health Care. 2022;31(2):85-91. doi: 10.1097/QMH.0000000000000339.
9
Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes.轻度疾病严重程度的 COVID-19 患者的消化症状:临床表型、粪便病毒 RNA 检测和结局。
Am J Gastroenterol. 2020 Jun;115(6):916-923. doi: 10.14309/ajg.0000000000000664.
10
The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.SARS-CoV-2 传播的独特特征:与 SARS-CoV、MERS-CoV 和 2009 年 H1N1 大流行性流感病毒的比较。
Rev Med Virol. 2021 Mar;31(2):e2171. doi: 10.1002/rmv.2171. Epub 2020 Sep 18.

引用本文的文献

1
Association of HLA-B gene polymorphism and blood groups with COVID-19 susceptibility and severity.HLA - B基因多态性及血型与新型冠状病毒肺炎易感性和严重程度的关联
Sci Rep. 2025 Aug 28;15(1):31775. doi: 10.1038/s41598-025-15455-1.
2
Long COVID-19: A Concept Analysis.长新冠:一项概念分析。
Infect Dis Rep. 2025 Jul 29;17(4):90. doi: 10.3390/idr17040090.
3
A descriptive study on feasibility of nasopharyngeal and oropharyngeal swab collection from pediatric research participants in Cebu, Philippines.关于从菲律宾宿务市儿科研究参与者中采集鼻咽拭子和口咽拭子的可行性的描述性研究。

本文引用的文献

1
On the origin and continuing evolution of SARS-CoV-2.关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的起源及持续进化
Natl Sci Rev. 2020 Jun;7(6):1012-1023. doi: 10.1093/nsr/nwaa036. Epub 2020 Mar 3.
2
Temperature Decreases Spread Parameters of the New Covid-19 Case Dynamics.温度降低新型新冠病毒病例动态的传播参数。
Biology (Basel). 2020 May 3;9(5):94. doi: 10.3390/biology9050094.
3
Petechial Skin Rash Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.与严重急性呼吸综合征冠状病毒2感染相关的瘀点性皮疹
Front Public Health. 2025 Jun 10;13:1566688. doi: 10.3389/fpubh.2025.1566688. eCollection 2025.
4
Bone Mineral Density, Bone Biomarkers, and Joints in Acute, Post, and Long COVID-19: A Systematic Review.急性、康复期及长期新冠病毒感染后的骨密度、骨生物标志物和关节:一项系统综述
Viruses. 2024 Oct 30;16(11):1694. doi: 10.3390/v16111694.
5
Trends in symptom prevalence and sequential onset of SARS-CoV-2 infection from 2020 to 2022 in East and Southeast Asia: a trajectory pattern exploration based on summary data.2020年至2022年东亚和东南亚地区新冠病毒感染症状流行趋势及症状相继出现情况:基于汇总数据的轨迹模式探索
Arch Public Health. 2024 Aug 15;82(1):125. doi: 10.1186/s13690-024-01357-7.
6
Lithium in the time of COVID: forever vigilant.新冠疫情下的锂:永远保持警惕。
Int J Bipolar Disord. 2024 Aug 7;12(1):29. doi: 10.1186/s40345-024-00351-w.
7
Factors Associated With Surveillance Testing in Individuals With COVID-19 Symptoms During the Last Leg of the Pandemic: Multivariable Regression Analysis.与大流行最后阶段 COVID-19 症状个体监测检测相关的因素:多变量回归分析。
JMIR Public Health Surveill. 2024 Jul 18;10:e52762. doi: 10.2196/52762.
8
Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?格林-巴利综合征:新冠病毒疫苗接种后的一种自身免疫性疾病?
Clin Immunol Commun. 2022 Dec;2:1-5. doi: 10.1016/j.clicom.2021.12.002. Epub 2021 Dec 23.
9
The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight.症状在 COVID-19 诊断模型中的预测作用:纵向观察。
Epidemiol Infect. 2024 Jan 22;152:e37. doi: 10.1017/S0950268824000037.
10
Risk Factors for Long COVID in Older Adults.老年人长期新冠的风险因素
Biomedicines. 2023 Nov 8;11(11):3002. doi: 10.3390/biomedicines11113002.
JAMA Dermatol. 2020 Jul 1;156(7):820-822. doi: 10.1001/jamadermatol.2020.1741.
4
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
5
Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study.基于众包数据的 2019 年冠状病毒病早期流行病学分析:人群水平观察研究。
Lancet Digit Health. 2020 Apr;2(4):e201-e208. doi: 10.1016/S2589-7500(20)30026-1. Epub 2020 Feb 20.
6
Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission.60岁以下患者的肥胖是COVID-19住院治疗的一个风险因素。
Clin Infect Dis. 2020 Jul 28;71(15):896-897. doi: 10.1093/cid/ciaa415.
7
Nervous system involvement after infection with COVID-19 and other coronaviruses.感染 COVID-19 和其他冠状病毒后的神经系统并发症。
Brain Behav Immun. 2020 Jul;87:18-22. doi: 10.1016/j.bbi.2020.03.031. Epub 2020 Mar 30.
8
Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020.评估新加坡前 100 名 COVID-19 患者的监测和控制措施的有效性 - 2020 年 1 月 2 日至 2 月 29 日。
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):307-311. doi: 10.15585/mmwr.mm6911e1.
9
How will country-based mitigation measures influence the course of the COVID-19 epidemic?基于国家的缓解措施将如何影响新冠疫情的发展进程?
Lancet. 2020 Mar 21;395(10228):931-934. doi: 10.1016/S0140-6736(20)30567-5. Epub 2020 Mar 9.
10
World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).世界卫生组织宣布全球紧急状态:对 2019 年新型冠状病毒(COVID-19)的回顾。
Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26.